Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease
The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2022-10, Vol.74, p.128942-128942, Article 128942 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 128942 |
---|---|
container_issue | |
container_start_page | 128942 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 74 |
creator | Foot, Jonathan S. Buson, Alberto Deodhar, Mandar Findlay, Alison D. Robertson, Alan D. Turner, Craig I. Yow, Tin Zhou, Wenbin Jarolimek, Wolfgang |
description | The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.
[Display omitted]
The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation. |
doi_str_mv | 10.1016/j.bmcl.2022.128942 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2703417705</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X22004188</els_id><sourcerecordid>2703417705</sourcerecordid><originalsourceid>FETCH-LOGICAL-c263t-c70487cd9c7ede02790082128868402e57afb88a70283227a60f08ee84156c0c3</originalsourceid><addsrcrecordid>eNp9kLFOHDEQhi2USFxIXiCVS5q9jL2-tU9KAycgSEg0REpnee1ZMqe1DfaCOJ6ePR0NDdVI__zfSPMx9lPAUoDofm2XffTjUoKUSyHNWskjthCqU02rYPWFLWDdQTPn_47Zt1q3AEKBUgu22-TYU6J0z2NO2UVKyPMLBVeRn3OXAq8YybvSu1cK2FRMlSZ6Rv6xi-l1F5FT-k_9vM-JT5m7EArWOqfD6GJ0Uy47HqjiTHxnXwc3VvzxPk_Y38uLu82f5ub26npzdtN42bVT4zUoo31Ye40BQeo1gJHzj6YzCiSutBt6Y5wGaVoptetgAINolFh1Hnx7wk4Pdx9KfnzCOtlI1eM4uoT5qVqpoVVCa1jNVXmo-pJrLTjYh0LRlZ0VYPee7dbuPdu9Z3vwPEO_DxDOTzwTFls9YfIYqKCfbMj0Gf4G3XmILQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2703417705</pqid></control><display><type>article</type><title>Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease</title><source>Elsevier ScienceDirect Journals</source><creator>Foot, Jonathan S. ; Buson, Alberto ; Deodhar, Mandar ; Findlay, Alison D. ; Robertson, Alan D. ; Turner, Craig I. ; Yow, Tin ; Zhou, Wenbin ; Jarolimek, Wolfgang</creator><creatorcontrib>Foot, Jonathan S. ; Buson, Alberto ; Deodhar, Mandar ; Findlay, Alison D. ; Robertson, Alan D. ; Turner, Craig I. ; Yow, Tin ; Zhou, Wenbin ; Jarolimek, Wolfgang</creatorcontrib><description>The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.
[Display omitted]
The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2022.128942</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Amine oxidase ; MAO-A ; MAO-B ; SSAO ; VAP-1 ; Vinyl fluoride</subject><ispartof>Bioorganic & medicinal chemistry letters, 2022-10, Vol.74, p.128942-128942, Article 128942</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c263t-c70487cd9c7ede02790082128868402e57afb88a70283227a60f08ee84156c0c3</citedby><cites>FETCH-LOGICAL-c263t-c70487cd9c7ede02790082128868402e57afb88a70283227a60f08ee84156c0c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X22004188$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Foot, Jonathan S.</creatorcontrib><creatorcontrib>Buson, Alberto</creatorcontrib><creatorcontrib>Deodhar, Mandar</creatorcontrib><creatorcontrib>Findlay, Alison D.</creatorcontrib><creatorcontrib>Robertson, Alan D.</creatorcontrib><creatorcontrib>Turner, Craig I.</creatorcontrib><creatorcontrib>Yow, Tin</creatorcontrib><creatorcontrib>Zhou, Wenbin</creatorcontrib><creatorcontrib>Jarolimek, Wolfgang</creatorcontrib><title>Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease</title><title>Bioorganic & medicinal chemistry letters</title><description>The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.
[Display omitted]
The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.</description><subject>Amine oxidase</subject><subject>MAO-A</subject><subject>MAO-B</subject><subject>SSAO</subject><subject>VAP-1</subject><subject>Vinyl fluoride</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kLFOHDEQhi2USFxIXiCVS5q9jL2-tU9KAycgSEg0REpnee1ZMqe1DfaCOJ6ePR0NDdVI__zfSPMx9lPAUoDofm2XffTjUoKUSyHNWskjthCqU02rYPWFLWDdQTPn_47Zt1q3AEKBUgu22-TYU6J0z2NO2UVKyPMLBVeRn3OXAq8YybvSu1cK2FRMlSZ6Rv6xi-l1F5FT-k_9vM-JT5m7EArWOqfD6GJ0Uy47HqjiTHxnXwc3VvzxPk_Y38uLu82f5ub26npzdtN42bVT4zUoo31Ye40BQeo1gJHzj6YzCiSutBt6Y5wGaVoptetgAINolFh1Hnx7wk4Pdx9KfnzCOtlI1eM4uoT5qVqpoVVCa1jNVXmo-pJrLTjYh0LRlZ0VYPee7dbuPdu9Z3vwPEO_DxDOTzwTFls9YfIYqKCfbMj0Gf4G3XmILQ</recordid><startdate>20221015</startdate><enddate>20221015</enddate><creator>Foot, Jonathan S.</creator><creator>Buson, Alberto</creator><creator>Deodhar, Mandar</creator><creator>Findlay, Alison D.</creator><creator>Robertson, Alan D.</creator><creator>Turner, Craig I.</creator><creator>Yow, Tin</creator><creator>Zhou, Wenbin</creator><creator>Jarolimek, Wolfgang</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20221015</creationdate><title>Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease</title><author>Foot, Jonathan S. ; Buson, Alberto ; Deodhar, Mandar ; Findlay, Alison D. ; Robertson, Alan D. ; Turner, Craig I. ; Yow, Tin ; Zhou, Wenbin ; Jarolimek, Wolfgang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c263t-c70487cd9c7ede02790082128868402e57afb88a70283227a60f08ee84156c0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Amine oxidase</topic><topic>MAO-A</topic><topic>MAO-B</topic><topic>SSAO</topic><topic>VAP-1</topic><topic>Vinyl fluoride</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Foot, Jonathan S.</creatorcontrib><creatorcontrib>Buson, Alberto</creatorcontrib><creatorcontrib>Deodhar, Mandar</creatorcontrib><creatorcontrib>Findlay, Alison D.</creatorcontrib><creatorcontrib>Robertson, Alan D.</creatorcontrib><creatorcontrib>Turner, Craig I.</creatorcontrib><creatorcontrib>Yow, Tin</creatorcontrib><creatorcontrib>Zhou, Wenbin</creatorcontrib><creatorcontrib>Jarolimek, Wolfgang</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Foot, Jonathan S.</au><au>Buson, Alberto</au><au>Deodhar, Mandar</au><au>Findlay, Alison D.</au><au>Robertson, Alan D.</au><au>Turner, Craig I.</au><au>Yow, Tin</au><au>Zhou, Wenbin</au><au>Jarolimek, Wolfgang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><date>2022-10-15</date><risdate>2022</risdate><volume>74</volume><spage>128942</spage><epage>128942</epage><pages>128942-128942</pages><artnum>128942</artnum><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.
[Display omitted]
The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.bmcl.2022.128942</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2022-10, Vol.74, p.128942-128942, Article 128942 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_2703417705 |
source | Elsevier ScienceDirect Journals |
subjects | Amine oxidase MAO-A MAO-B SSAO VAP-1 Vinyl fluoride |
title | Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T04%3A54%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combining%20monoamine%20oxidase%20B%20and%20semicarbazide-sensitive%20amine%20oxidase%20enzyme%20inhibition%20to%20address%20inflammatory%20disease&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Foot,%20Jonathan%20S.&rft.date=2022-10-15&rft.volume=74&rft.spage=128942&rft.epage=128942&rft.pages=128942-128942&rft.artnum=128942&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2022.128942&rft_dat=%3Cproquest_cross%3E2703417705%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2703417705&rft_id=info:pmid/&rft_els_id=S0960894X22004188&rfr_iscdi=true |